SCHEMBL9570977

SCHEMBL9570977

COc1ccc(Cl)cc1N1CCN(CC(CN)OC)CC1

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HTR3E A5X5Y0 1/20 0.53
HTR3B O95264 1/20 0.53
HTR3A P46098 1/20 0.53
HTR3D Q70Z44 1/20 0.53
HTR3C Q8WXA8 1/20 0.53
DRD2 P14416 1/20 0.50
DRD4 P21917 1/20 0.50
KDM4E B2RXH2 1/20 0.47
MAPT P10636 1/20 0.47
ALDH1A1 P00352 2/20 0.47
ADRA1D P25100 7/20 0.46
ADRA1A P35348 7/20 0.46
ADRA1B P35368 7/20 0.46
LMNA P02545 1/20 0.45
TACR3 P29371 1/20 0.43
FFAR4 Q5NUL3 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9017199 0.85 HTR3E (0.53) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL7410473 0.81 ALDH1A1 (0.68) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL8290816 0.79 ADRA1D (0.59) HTR3EHTR3BHTR3AHTR3DHTR3C
Hydrochloric Acid SCHEMBL6935545 0.78 ADRA1D (0.58) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL7549051 0.77 DRD2 (0.65) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL9017194 0.76 RECQL (0.69) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL27405596 0.76 HTR3E (0.59) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL5650916 0.76 HTR3E (0.59) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL9570990 0.75 ADRA1D (0.72) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL4336114 0.74 HTR3E (0.69) HTR3EHTR3BHTR3AHTR3DHTR3C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5244901-A Multistage preparation by starting with a phenylpiperazine and an epoxide or chloro alcohol containing a phthalimido group; use to treat disorders involving hyperactivity of the alpha 1-adrenergic system SYNTHELABO (FR) 1993-09-14 US disclosed
EP-0522915-A1 Pyrimidine-4-carboxamide derivatives, their preparation and their use in therapeutics SYNTHELABO (FR) 1993-01-13 EP disclosed